Michael Smith Laboratories
-
As of March 2024, the university has raised more than $33.4 million towards its goal of $100 million for the Student Affordability Initiative through FORWARD, the fundraising campaign for UBC.
-
Fungus in a test tube first step to curing ‘corn smut’
Researchers have mimicked a corn plant’s make-up in the lab to investigate ‘corn smut’, opening the door to finding a cure for the disease.
-
UBC researchers train computers to predict the next designer drugs
UBC researchers have trained computers to predict the next designer drugs before they are even on the market, technology that could save lives.
-
Beyond COVID-19: How mRNA technology could transform how we treat disease
Dr. Anna Blakney, assistant professor at UBC’s Michael Smith Laboratories and school of biomedical engineering, describes how mRNA technology could transform how we treat disease.
-
Debunking COVID-19 myths: As the weather warms, UBC vaccine expert separates fact from fiction
Dr. Anna Blakney, assistant professor in UBC’s School of Biomedical Engineering, Michael Smith Laboratories and vaccine expert, addresses some popular myths about COVID-19.
-
New protein “switch” could be key to controlling blood-poisoning and preventing death
Scientists at the University of British Columbia have discovered a new protein “switch” that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
